Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
2003 1
2005 2
2006 1
2007 1
2011 1
2012 1
2013 2
2015 2
2016 2
2017 1
2018 1
2019 1
2021 3
2022 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Bhatt DL, et al. N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415628 Clinical Trial.
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Verma S, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Dhingra NK, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Budoff MJ, Mason RP, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Verma S, et al. Circulation. 2021 Dec 7;144(23):1845-1855. doi: 10.1161/CIRCULATIONAHA.121.056290. Epub 2021 Oct 28. Circulation. 2021. PMID: 34710343 Free article. Clinical Trial.
Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT.
Burger PM, Bhatt DL, Dorresteijn JAN, Koudstaal S, Mosterd A, Martens FMAC, Steg PG, Visseren FLJ; REDUCE-IT Investigators. Burger PM, et al. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 4;10(6):488-499. doi: 10.1093/ehjcvp/pvae030. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38678009 Free PMC article. Clinical Trial.
Multi-region investigation of 'man' as default in attitudes.
Phills CE, Miller JK, Buchanan EM, Williams A, Meyers C, Brown ER, Zickfeld J, Volsa S, Stieger S, Oberzaucher E, Mlakic V, Vasilev M, Dalgar İ, Çoksan S, Söylemez S, Solak Ç, Özdoğru AA, Çoktok B, Kung CC, Suavansri P, Manley H, Álvarez-Solas S, Ricaurte DZ, Ropovik I, Baník G, Babinčák P, Adamkovič M, Kačmár P, Hricová M, Bavoľár J, Li L, Gao F, Chen Z, Ković V, Gvozdenović V, Arriaga P, Filip K, Barzykowski K, Adamus S, Pfuhl G, Martiny SE, Klevjer K, Woelfert FS, Tamnes CK, Kunst JR, Korbmacher M, Singh MM, Pradhan S, Parveen N, Parganiha A, Pande B, Kujur P, Chandel P, Reggev N, Mokady A, Papadatou-Pastou M, Schnepper R, Röer JP, Ripp T, Pronizius E, Lamm C, Voracek M, Olsen J, Enachescu J, Batres C, Storage D, Levitan CA, Li M, Vaughn LA, Chopik WJ, Schmidt K, Mallik PR, Lewis S, Leach B, Jurosic B, Moreau D, Ndukaihe ILG, Arinze NC, Janssen SMJ, Foo A, Tan CBY, Williams GP, Riis D, Lane BM, Lynott D, Evans TR, Sirota M, Holford DL, Werner KM, Wang K, Milyavskaya M, Stephen ID, Ross RM, Roberts A, Ghasemi O, Steffens NK, Peters K, Dixson B, Varella MAC, Valentova JV, Mafra AL, Hsu RMCS, de Moraes YL, da Silva LO, da Silva CSA, Helmy M, Balderrama M, Al-Hoorie AH, McGe… See abstract for full author list ➔ Phills CE, et al. Among authors: ripp t. PLoS One. 2025 Jun 25;20(6):e0323938. doi: 10.1371/journal.pone.0323938. eCollection 2025. PLoS One. 2025. PMID: 40560856 Free PMC article.
Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial.
Beckett N, Peters R, Tuomilehto J, Swift C, Sever P, Potter J, McCormack T, Forette F, Gil-Extremera B, Dumitrascu D, Staessen JA, Thijs L, Fletcher A, Bulpitt C; HYVET Study Group. Beckett N, et al. BMJ. 2011 Jan 4;344:d7541. doi: 10.1136/bmj.d7541. BMJ. 2011. PMID: 22218098 Clinical Trial.
22 results